Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in
low-resource settings is a global health priority, as emphasised by research showing the …

Despite immense progress in antiretroviral therapy (ART) scale-up, many people still lack
access to basic standards of care, with our ability to meet the Joint United Nations …

When antiretroviral therapy (ART) scale up began in Africa a decade ago, there was concern
that lack of laboratory monitoring for patients receiving antiretroviral drugs would be an …

To achieve global targets for universal treatment set forth by the Joint United Nations
Programme on human immunode ficiency virus (HIV)/acquired immunodeficiency syndrome …

uscript particularly challenging in Southern Africa, due to the lack of trained laboratory
personnel, high costs of centralised laboratory infrastructure, and challenges with specimen …

Abstract Background World Health Organization guidelines now recommend routine use of
viral load testing, where available, for patients receiving antiretroviral treatment (ART) …

Abstract The South African antiretroviral treatment guidelines recommend the use of human
immunodeficiency virus type 1 (HIV-1) load testing for patient monitoring and, in particular, to …

Background In low-income countries, the use of laboratory monitoring of patients taking
antiretroviral therapy (ART) remains controversial in view of persistent resource constraints …

The cost of combination HIV antiretroviral treatment has plummeted in the past 12 months so
that now highly active antiretroviral therapy (HAART) can be purchased for less than US …

Background: Increased eligibility guidelines of antiretroviral therapy (ART) may lead to
greater routine viral load monitoring. However, in resource-constrained settings, the …